Bayer inks US$1.55bn cancer deal with Loxo Oncology

08:57 EDT 1 Apr 2019 | European Biotechnology News

Original Article: Bayer inks US$1.55bn cancer deal with Loxo Oncology

More From BioPortfolio on "Bayer inks US$1.55bn cancer deal with Loxo Oncology"